Pulmonary function in spinal muscular atrophy

Area of Science:

• Neurology
• Pulmonology
• Pediatrics

Background:

• Spinal muscular atrophy (SMA) is a progressive neuromuscular disease affecting motor neurons.
• Pulmonary complications are a major cause of morbidity and mortality in SMA patients.
• Limited prospective data exists on pulmonary function changes in pediatric SMA populations.

Purpose of the Study:

• To prospectively evaluate pulmonary function, specifically forced vital capacity (FVC), in pediatric SMA patients.
• To correlate FVC with motor function categories and track changes over time.
• To identify pulmonary function alterations as determinants of function and survival in SMA.

Main Methods:

• A prospective study involving 77 SMA patients (ages 5-18) across three centers.
• Assessment of forced vital capacity (FVC) using height as a predictor.
• Categorization of patients into four motor function levels.
• Longitudinal FVC monitoring in 40 patients over 1.1 to 4.4 years.

Main Results:

• FVC correlated with motor function, with highest-functioning groups showing normal values and those sitting with support showing the lowest.
• Despite height growth in 88% of patients, only 35% showed increased height-adjusted FVC percent.
• A significant proportion of patients, particularly those with lower motor function, experienced a decline in height-adjusted FVC over time.
• Basic FVC decreased in 43% of cases, irrespective of height adjustments.

Conclusions:

• Pulmonary function, particularly FVC, deteriorates in many pediatric SMA patients, even those with higher motor function.
• Declines in pulmonary function are linked to motor function and survival outcomes in SMA.
• Regular pulmonary function monitoring is essential for managing SMA patients.